{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:07:11Z","timestamp":1793387231031,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015537","name":"Department of Pathology and Laboratory Medicine, University of North Carolina School of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007707","name":"University of California Davis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007707","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.anndiagpath.2025.152437","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T12:13:44Z","timestamp":1736511224000},"page":"152437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Morphologic and immunohistochemical characterization of small and large duct cholangiocarcinomas in a Western cohort: A panel of pCEA, CRP, N-cadherin, and albumin in situ hybridization aids in subclassification"],"prefix":"10.1016","volume":"75","author":[{"given":"Raymond","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongming E.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Matsukuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.anndiagpath.2025.152437_bb0005","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1634\/theoncologist.2015-0446","article-title":"Forty-year trends in cholangiocarcinoma incidence in the U.S.: intrahepatic disease on the rise","volume":"21","author":"Saha","year":"2016","journal-title":"Oncologist"},{"issue":"12","key":"10.1016\/j.anndiagpath.2025.152437_bb0010","doi-asserted-by":"crossref","first-page":"419","DOI":"10.4254\/wjh.v2.i12.419","article-title":"Pathological classification of intrahepatic cholangiocarcinoma based on a new concept","volume":"2","author":"Nakanuma","year":"2010","journal-title":"World J Hepatol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152437_bb0015","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1038\/modpathol.2011.41","article-title":"Viral hepatitis is associated with intrahepatic cholangiocarcinoma with cholangiolar differentiation and N-cadherin expression","volume":"24","author":"Yu","year":"2011","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2025.152437_bb0020","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.anndiagpath.2025.152437_bb0025","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/PAS.0000000000000670","article-title":"Distinct Clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic Cholangiocarcinoma","volume":"40","author":"Hayashi","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"10.1016\/j.anndiagpath.2025.152437_bb0030","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/PAS.0000000000001006","article-title":"MDM2 amplification in intrahepatic cholangiocarcinomas: its relationship with large-duct type morphology and uncommon KRAS mutations","volume":"42","author":"Kim","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"25","key":"10.1016\/j.anndiagpath.2025.152437_bb0035","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1038\/onc.2012.315","article-title":"Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas","volume":"32","author":"Wang","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.anndiagpath.2025.152437_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1321683","article-title":"Clinical management of intrahepatic cholangiocarcinoma: surgical approaches and systemic therapies","volume":"14","author":"Ruff","year":"2024","journal-title":"Front Oncol"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152437_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cld.2009.11.009","article-title":"Epidemiology of hepatitis B and C viruses: a global overview","volume":"14","author":"Te","year":"2010","journal-title":"Clin Liver Dis"},{"issue":"9","key":"10.1016\/j.anndiagpath.2025.152437_bb0050","first-page":"796","article-title":"Global, regional, and national burden of hepatitis B, 1990-2019: a systematic analysis for the global burden of disease study 2019. Lancet","volume":"7","author":"Collaborators","year":"2022","journal-title":"Gastroenterol Hepatol"},{"issue":"13","key":"10.1016\/j.anndiagpath.2025.152437_bb0055","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3748\/wjg.v30.i13.1836","article-title":"Hepatolithiasis: epidemiology, presentation, classification and management of a complex disease","volume":"30","author":"Motta","year":"2024","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2025.152437_bb0060","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/PAS.0000000000001118","article-title":"Intrahepatic Cholangiocarcinomas have histologically and Immunophenotypically distinct small and large duct patterns","volume":"42","author":"Sigel","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2025.152437_bb0065","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/PAS.0000000000000957","article-title":"C-reactive protein (CRP) is a promising diagnostic Immunohistochemical marker for intrahepatic Cholangiocarcinoma and is associated with better prognosis","volume":"41","author":"Yeh","year":"2017","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"10.1016\/j.anndiagpath.2025.152437_bb0070","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/s41379-019-0290-0","article-title":"Immunohistochemical and molecular features of cholangiolocellular carcinoma are similar to well-differentiated intrahepatic cholangiocarcinoma","volume":"32","author":"Balitzer","year":"2019","journal-title":"Mod Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152437_bb0075","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.humpath.2020.12.005","article-title":"An immunostaining panel of C-reactive protein, N-cadherin, and S100 calcium binding protein P is useful for intrahepatic cholangiocarcinoma subtyping","volume":"109","author":"Akita","year":"2021","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152437_bb0080","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1097\/PAS.0000000000002224","article-title":"An Immunohistochemical analysis of Osteopontin and S100 calcium-binding protein P is useful for subclassifying large- and small-duct type intrahepatic Cholangiocarcinomas","volume":"48","author":"Yoshizawa","year":"2024","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152437_bb0085","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/modpathol.2017.22","article-title":"Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas","volume":"30","author":"Akita","year":"2017","journal-title":"Mod Pathol"},{"issue":"2","key":"10.1016\/j.anndiagpath.2025.152437_bb0090","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.path.2018.02.005","article-title":"Cholangiocarcinoma","volume":"11","author":"Krasinskas","year":"2018","journal-title":"Surg Pathol Clin"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152437_bb0095","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1002\/hep.25595","article-title":"Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes","volume":"55","author":"Komuta","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.anndiagpath.2025.152437_bb0100","series-title":"Digestive system tumours","first-page":"254","article-title":"Intrahepatic cholangiocarcinoma","author":"Nakanuma","year":"2019"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152437_bb0105","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1111\/j.1365-2559.2007.02735.x","article-title":"A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: 'bile ductular carcinoma'","volume":"51","author":"Kozaka","year":"2007","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152437_bb0110","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/jclinpath-2019-206055","article-title":"Cholangiolar pattern and albumin in situ hybridisation enable a diagnosis of intrahepatic cholangiocarcinoma","volume":"73","author":"Brackett","year":"2020","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.anndiagpath.2025.152437_bb0115","unstructured":"MedCalc Software Ltd., Comparison of Proportions Calculator. [22.023; accessed 04\/09\/2024] 2023; Available from: https:\/\/www.medcalc.org\/calc\/comparison_of_proportions.php."},{"key":"10.1016\/j.anndiagpath.2025.152437_bb0120","unstructured":"MedCalc Software Ltd., Diagnostic test evaluation calculator. [22.023; accessed 04\/09\/2024] 2023; Available from: https:\/\/www.medcalc.org\/calc\/diagnostic_test.php."},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152437_bb0125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/PAI.0000000000000882","article-title":"A subset of intrahepatic Cholangiocarcinomas express albumin RNA as detected by in situ hybridization","volume":"29","author":"Avadhani","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"3","key":"10.1016\/j.anndiagpath.2025.152437_bb0130","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/PAI.0000000000000885","article-title":"Utility and limitations of albumin mRNA in situ hybridization detection in the diagnosis of hepatobiliary lesions and metastatic carcinoma to the liver","volume":"29","author":"Collins","year":"2021","journal-title":"Appl Immunohistochem Mol Morphol"},{"issue":"7","key":"10.1016\/j.anndiagpath.2025.152437_bb0135","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/modpathol.3880134","article-title":"Immunohistochemical analysis of hepatocellular and adenocarcinoma in the liver: MOC31 compares favorably with other putative markers","volume":"13","author":"Porcell","year":"2000","journal-title":"Mod Pathol"},{"issue":"12","key":"10.1016\/j.anndiagpath.2025.152437_bb0140","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1053\/hupa.2002.130104","article-title":"Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma","volume":"33","author":"Lau","year":"2002","journal-title":"Hum Pathol"},{"issue":"6","key":"10.1016\/j.anndiagpath.2025.152437_bb0145","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1365-2559.2012.04316.x","article-title":"S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas","volume":"61","author":"Tsai","year":"2012","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.anndiagpath.2025.152437_bb0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1148\/rg.2021200087","article-title":"Gallbladder carcinoma and its differential diagnosis at MRI: what radiologists should know","volume":"41","author":"Lopes Vendrami","year":"2021","journal-title":"Radiographics"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913425000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T20:35:13Z","timestamp":1740515713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913425000024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":30,"alternative-id":["S1092913425000024"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152437","relation":{},"ISSN":["1092-9134"],"issn-type":[{"value":"1092-9134","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morphologic and immunohistochemical characterization of small and large duct cholangiocarcinomas in a Western cohort: A panel of pCEA, CRP, N-cadherin, and albumin in situ hybridization aids in subclassification","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152437"}}